UGT1A1 and fatty liver disease: The increase in plasma bilirubin levels observed in the present study (~10-fold) reflects the high degree of inhibition of hepatic UGT1A1 by GNUR, which decreased hepatic steatosis in our model of dietary-induced obesity.